Oxymetazoline Hydrochloride Concentrated Vapor Nasal Spray, 3/4 FL OZ (22 mL) | OXYMETAZOLINE HYDROCHLORIDE
Oxymetazoline hydrochloride 0.05%
Nasal decongestant
■ a cold ■ hay fever ■ upper respiratory allergies
Ask a doctor before use if you have
■ heart disease ■ high blood pressure ■ thyroid disease ■ diabetes
■ trouble urinating due to an enlarged prostate gland
Stop use and ask a doctor if symptoms persist.
If pregnant or breast-feeding, ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
2 or 3 sprays in each nostril not more than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
Shake well before use. Before using the first time, remove the protective cap from the tip and prime metered pump by depressing firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress pump all the way down with a firm even stroke and sniff deeply. Wipe nozzle clean after use.
benzalkonium chloride solution, camphor, edetate disodium, eucalyptol, glycin, menthol, polyethylene glycol, polysorbate 80, propylene glycol, purified water, sodium chloride, sodium hydroxide.
Manufactured by:
Cadila Healthcare Ltd.
Ahmedabad, India
Distributed by:
Zydus Pharmaceuticals USA Inc.
Pennington, NJ 08534
Rev.: 05/11
Revision Date: 05/31/2011
NDC 68382-418-07
Oxymetazoline Hydrochloride Concentrated Vapor Nasal Spray, ¾ FL OZ (22 mL)
Rx only
Zydus


Manufacturer
Zydus Pharmaceuticals (USA) Inc.
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 31st of January 2012
Medications 1909 Associated Medications 
Oxymetazoline hydrochloride
Oxymetazoline Hydrochloride Concentrated Vapor Nasal Spray, 3/4 FL OZ (22 mL)
Rx act nasal
HEB Nasal Spray Drug Facts
Healthy accents nasal
DZA Brands, LLC Nasal Spray Drug Facts
Good sense nasal
Perrigo Nasal Spray Drug Facts
Nasal
CVS Pharmacy, Inc. Nasal Spray Drug Facts
Clinical Trials 1505 Associated Clinical Trials 
Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)(COMPLETED)
The primary objective of this study is to evaluate the efficacy of the combination of mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY) given together once a day in...
Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-Allergic Rhinitis in Subjects With Persistent Nasal Congestion
Nasal glucocorticosteroids (GCS) are considered first-line therapy for both allergic and non-allergic rhinitis.1-3 Nasal congestion can persist despite maximum treatment with intranasal G...
Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis
The purpose of this study is to determine if Astepro Nasal Spray (0.1% azelastine hydrochloride) is as safe as Astelin Nasal Spray (0.1% azelastine hydrochloride)
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
The purpose of the study is to assess the safety of the study drug, Patanase (Olopatadine Hydrochloride Nasal Spray 0.6%) compared to placebo (inactive substance) in children ages 2 to les...
A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies
The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone
PubMed Articles 3539 Associated PubMed Articles 
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
BACKGROUND: A proof-of-concept study suggested that combination therapy with commercial azelastine hydrochloride nasal spray and fluticasone propionate nasal spray significantly improved nasal symptom...
A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.
BACKGROUND: Oxymetazoline and xylometazoline are locally effective and direct acting drugs that relieve nasal congestion. The aim of this study was to objectively determine and compare the decongestiv...
Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: Evidence for the involvement of UGT1A9.
The incubation of oxymetazoline, a nonprescription nasal decongestant, with human liver microsomes (HLMs) supplemented with uridine-5-diphosphoglucuronic acid (UDPGA) generated glucuronide metabolite...
Powered-assisted partial turbinectomy versus mometasone furoate nasal spray for relief of nasal blockage in chronic or idiopathic rhinosinusitis.
Abstract Conclusion: Power-assisted turbinectomy is a safe and reliable alternative for patients with nasal blockage if nasal corticosteroid spray therapy is not suitable. Objective: Powered-assisted...
Septoplasty and decongestant improve distribution of nasal spray.
This study prospectively examined the intranasal distribution of nasal spray after nasal septal correction and decongestant administration. A cohort of 20 patients was assessed for the distribution of...